(Q46088442)

English

A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG).

scientific article published on 20 March 2012

Statements

A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG). (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit